Home Myriad Genetics Upgraded by Credit Suisse to "Neutral"
 

Keywords :   


Myriad Genetics Upgraded by Credit Suisse to "Neutral"

2014-02-09 03:19:34| Biotech - Topix.net

The firm currently has a $29.00 target price on the stock. Credit Suisse's price objective indicates a potential downside of 10.02% from the stock's previous close.

Tags: credit suisse neutral genetics

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
23.11
23.11 NEXT
23.11
23.11(Rawlings)
23.11 DVD2
23.11
23.11 US Orig LP The Soul Searchers Salt Of ~
23.11Switch SR SL LED 2
More »